These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 21420365

  • 1. Neuroprotective agents: cannabinoids.
    Sánchez AJ, García-Merino A.
    Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
    [Abstract] [Full Text] [Related]

  • 2. Cannabinoid system and neuroinflammation: implications for multiple sclerosis.
    Correa F, Docagne F, Mestre L, Loría F, Hernangómez M, Borrell J, Guaza C.
    Neuroimmunomodulation; 2007 Jan; 14(3-4):182-7. PubMed ID: 18073512
    [Abstract] [Full Text] [Related]

  • 3. Role of CB2 receptors in neuroprotective effects of cannabinoids.
    Fernández-Ruiz J, Pazos MR, García-Arencibia M, Sagredo O, Ramos JA.
    Mol Cell Endocrinol; 2008 Apr 16; 286(1-2 Suppl 1):S91-6. PubMed ID: 18291574
    [Abstract] [Full Text] [Related]

  • 4. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
    Liblau R.
    J Neurol Sci; 2009 Dec 16; 287 Suppl 1():S17-23. PubMed ID: 20106343
    [Abstract] [Full Text] [Related]

  • 5. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.
    Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B, Möller T, Brosnan C, Stella N.
    Proc Natl Acad Sci U S A; 2006 Apr 18; 103(16):6362-7. PubMed ID: 16571660
    [Abstract] [Full Text] [Related]

  • 6. [The role of endocannabinoid system in physiological and pathological processes in the eye].
    Nadolska K, Goś R.
    Klin Oczna; 2008 Apr 18; 110(10-12):392-6. PubMed ID: 19195174
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
    Croxford JL, Pryce G, Jackson SJ, Ledent C, Giovannoni G, Pertwee RG, Yamamura T, Baker D.
    J Neuroimmunol; 2008 Jan 18; 193(1-2):120-9. PubMed ID: 18037503
    [Abstract] [Full Text] [Related]

  • 8. [Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis].
    Mestre L, Correa F, Docagne F, Clemente D, Ortega-Gutiérrez S, Arévalo-Martín A, Molina-Holgado E, Borrell J, Guaza C.
    Rev Neurol; 2008 Jan 18; 43(9):541-8. PubMed ID: 17072810
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.
    Docagne F, Muñetón V, Clemente D, Ali C, Loría F, Correa F, Hernangómez M, Mestre L, Vivien D, Guaza C.
    Mol Cell Neurosci; 2007 Apr 18; 34(4):551-61. PubMed ID: 17229577
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG.
    Int J Obes (Lond); 2006 Apr 18; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L.
    Brain; 2011 Sep 18; 134(Pt 9):2722-35. PubMed ID: 21908876
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
    Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernández-Ruiz J.
    Neurobiol Dis; 2005 Sep 18; 19(1-2):96-107. PubMed ID: 15837565
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.